Companies in Agriculture technology sector are fighting to create new strains of cannabis plants that can result to constant levels of cannabinoid and hence provide consumers with consistent, predictable impacts
Levels of cannabinoid. The objective is far from new—and probably ancient. Currently, leading plant scientists are trying to establish multi-million dollar labs for massive retail cannabis companies, rather than black market breeders and growers.
Most of the recent cannabis strains result from the efforts to produce top class strains which offer users with consistent effects. But the rapidly growing global cannabis industry has developed significant opportunities for companies to license their strains. And due to a high level of competition for cannabis extracts and concentrates providing more beneficial effects and a higher rate of control over dosage, the demand for the useful flower is higher than ever.
Cannabis sativa is a plant consisting of different kinds of smells, tastes, appearance, and effects. And growers tend to exploit that variety to cultivate strains that result in a specific feature set, leading to the massive multiplication of cannabis strains that are currently available. Growers and retailers tend to classify this variety with a type of ad hoc classification system. If a strain gives you a feeling of sleepiness and relaxation then call it an indica. If the cannabis strain gives you energy and sense of perceptions, then call it a sativa.
However, differences within particular strains are often more significant than variations between them. Thus the terminology of most recent cannabis strains are meaningless and only meant for marketing. There exists nothing in the DNA of a specific strain or the means in which those genes express themselves in a plant that connects to its name. For instance, a particular grower’s strain of Lemon Kush might continually provide similar citrusy flavors and a high relaxation effect. However, another type of strain at another dispensary could be less potent than others. Therefore consumers often lack the notion of what they’re receiving when they purchase flower.
On the other hand, some consumers think that the lack of predictability in flower is disturbing. Those consumers are shifting to different products, such as oils, edibles, tinctures, concentrates, and capsules.
Market projections of the legal U.S. cannabis industry indicate that consumer trends play a significant role. Some consumers are happy with what they understand and smoking traditional flower. However, a growing proportion of the market is shifting in favor of cannabis concentrates which provide more consistency and wariness. The sales of flowers are increasing. Surprisingly, BDS Analytics forecasts an $8.5 billion retail flower market by 2022, resulting in a compound annual growth rate of 14.8 percent.
However, there are still questions about the long-term fate of flowers, will smoking marijuana potentially become outdated, overtaken by vape pens, dab rigs, and elixirs? Organizations such as Front Range Biosciences and Phylos Bioscience are installing leading plant scientists enable that it doesn’t occur. These scientists aim to develop new genetic breeding methods that can create strains which are consistent and well-established.
